Press Releases

 
Press Releases
  Date Title View
Dec 18, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - December 18, 2003 - Dynavax Technologies Corporation, a privately held biopharmaceutical company, announced today that the United States Patent and Trademark Office (USPTO) has de...
Nov 3, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berna Biotech Ltd Béatrice Keller Communications Manager communications@bernabiotech.com Phone +41 (0) 31 980 6522 Fax +41 (0) 31 980 6229 Ber...
Oct 24, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - October 24, 2003 - Dynavax Technologies Corporation announced today that it has filed a registration statement with the Securities and Exchange Commission for the initial public o...
Aug 4, 2003
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA - August 4, 2003 - Dynavax Technologies Corporation today announced the appointment of Daniel Levitt, M.D., Ph.D., to the position of vice president and chief medical officer. He...
Sep 4, 2002
Contact: Dino Dina, M.D. President and Chief Executive Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, September 4, 2002 - Dynavax Technologies, a privately held biopharmaceutical company, today announced it has initiated a Phase II clinical study to evaluate the abilit...
Aug 22, 2002
Contact: Dynavax Technologies Corporation Dino Dina, M.D. President and CEO 510-848-5100 Berkeley, CA -- August 22, 2002 - Dynavax Technologies Corporation today announced the appointment of William J. Dawson to the position of vice president, finance and operations, and chief financial o...
Apr 25, 2002
Contact: Andrew Gengos Chief Financial Officer Dynavax Technologies Corporation (510) 848-5100 Berkeley, CA, April 25, 2002 - Dynavax Technologies, a privately held biopharmaceutical company, today announced that it had raised $34.8 million in a private placement of its Series D Preferred St...
Dec 6, 2000
Contact: Dino Dina, M.D. President and CEO Dynavax Technologies Corporation (510) 848-5100 or (877) 848-5100 Berkeley, CA, December 6, 2000 - Dynavax Technologies Corporation today announced that it has named three new vice presidents, including Robert Lee Coffman, Ph.D., as Vice Preside...
FirstPrevious
...
41
= add release to Briefcase